Skip to Content

GS TEW 50 mg (Tafinlar 50 mg)

Generic Name: dabrafenib

Pill with imprint GS TEW 50 mg is Red, Capsule-shape and has been identified as Tafinlar 50 mg. It is supplied by GlaxoSmithKline.

Tafinlar is used in the treatment of melanoma, metastatic; non-small cell lung cancer; thyroid cancer and belongs to the drug class multikinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Tafinlar 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GS TEW 50 mg

Tafinlar 50 mg GS TEW 50 mg

Tafinlar

Generic Name
dabrafenib
Imprint
GS TEW 50 mg
Strength
50 mg
Color
Red
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Multikinase inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
GlaxoSmithKline

Labelers / Repackagers

NDC CodeLabeler / Repackager
00173-0846 GlaxoSmithKline
00078-0682 Novartis Pharmaceuticals Corporation

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.